-
Trinity Academic Cancer Trials Group awarded over €2million from the HRB
The Trinity Academic Cancer Trials Group, a Health Research Board (HRB) partnership supporting cancer clinical trials to improve health and care. The funding will improve survival and quality of life for patients with cancer.
21 Dec 2021
Research
-
Overcoming the challenge of digital inclusion for adults with intellectual disability
The Digi-ID project, in the Trinity Centre for Ageing with an Intellectual Disability (TCAID) aims to address the challenge of digital inclusion and low usage of digital technologies amongst people with intellectual disability (ID).
21 Dec 2021
Research
-
First patient in Ireland receives ground-breaking cell therapy for blood cancer
The patient in Ireland received the treatment at Trinity St James’s Cancer Institute. Patient is infused with own genetically modified cells using innovative CAR-T therapy.
20 Dec 2021
Research
-
OncoMark acquired by US molecular diagnostic company, Cepheid Inc.
Trinity's Professor Adrian Bracken spearheaded the research that initially led to the identification of a panel of genetic drivers of breast cancer, and which gave rise to a novel cancer test developed by the company.
16 Dec 2021
Research
-
Severe-COVID patients risk an increase in mortality rate when cared for outside of an ICU
Study points to Ireland having one of the lowest numbers of ICU beds in Europe and prompts calls from critical care consultants for urgent investment in critical care beds
15 Dec 2021
Research